FDA Approves Giapreza (angiotensin II) to Treat Dangerously Low Blood Pressure

December 21, 2017 -- The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock. " Shock, the inability to maintain...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news